{
  "created_at": "2020-09-08T04:43:16.000Z",
  "updated_at": "2021-01-06T08:25:08.012Z",
  "id": "6da37e97-1e02-4772-a29b-9dfe058023d2",
  "labels": "current-affairs,2020-09-09",
  "question": "Researchers of which organization have developed Diagnostic therapy drug candidate for lung cancer?",
  "option1": "AIIMS",
  "option2": "IIT Delhi",
  "option3": "JNCASR",
  "option4": "ICMR",
  "option5": "",
  "answer": "JNCASR",
  "explanation": "Researchers at Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR) have developed a theragnostic (diagnostic therapy) drug candidate for lung cancer. <br />JNCASR is an autonomous institute under the Department of Science &amp; Technology (DST), Govt. of India. Lung cancer is one of the most common cause of cancer related death and is tough to detect at early stages thereby making it difficult to treat."
}